Atzumi (Dihydroergotamine Mesylate) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Atzumi. Always confirm against the full prescribing information.
100 interactions
Acebutolol
Acebutolol may increase the vasoconstricting activities of Dihydroergotamine.
Level 2 evidence
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Dihydroergotamine.
Level 1 evidence
Albendazole
The metabolism of Dihydroergotamine can be decreased when combined with Albendazole.
Level 2 evidence
Alfentanil
The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Alfentanil.
Level 2 evidence
Alosetron
The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Alosetron.
Level 2 evidence
Alprazolam
The metabolism of Alprazolam can be decreased when combined with Dihydroergotamine.
Level 1 evidence
Amantadine
The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Amantadine.
Level 2 evidence
Amisulpride
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Amisulpride.
Level 2 evidence
Apalutamide
The serum concentration of Dihydroergotamine can be decreased when it is combined with Apalutamide.
Level 1 evidence
Apomorphine
The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Apomorphine.
Level 1 evidence
Aripiprazole
The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Aripiprazole.
Level 1 evidence
Aripiprazole lauroxil
The metabolism of Aripiprazole lauroxil can be decreased when combined with Dihydroergotamine.
Level 1 evidence
Enter your NPI to unlock 45 major interactions for Atzumi
Atzumi (Dihydroergotamine Mesylate) has 774 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Atzumi (Dihydroergotamine Mesylate) has 354 major, 288 moderate, and 132 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Atzumi. Always confirm against the full prescribing information.